Toxoplasmosis in Cats: Zoonotic Risk and Congenital Transmission

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a complex heteroxenous life cycle [1]. Felids, including domestic cats, serve as the definitive hosts in which sexual reproduction occurs exclusively within the intestinal epithelium [1, 2]. Following ingestion of tissue cysts from intermediate hosts (typically rodents or birds), bradyzoites invade feline enterocytes and undergo a series of asexual schizogonic cycles followed by gametogony [1, 2]. The developing sexual stages exhibit a distinct pattern of cell division characterized by proliferative expansion prior to differentiation [1]. A single-cell atlas of sexual development in the feline intestinal tract has revealed transcriptional programmes that govern stage conversion and oocyst wall formation [2]. MicroRNA expression dynamics in the feline small intestine during infection further illustrate host-pathogen interactions at the molecular level [3].

After fertilization, unsporulated oocysts are shed in cat feces. Shedding typically lasts one to three weeks and can produce millions of oocysts [2]. Environmental sporulation renders oocysts highly resistant to physical and chemical degradation [4]. Cats become infected through predation, ingestion of contaminated raw meat, or transplacentially [5]. Kittens may acquire infection via nursing or vertical transmission [6]. The entero-epithelial stage of infection can be detected using markers such as MIC17A, which serves as both an entero-epithelial and chronic stage marker [7].

Epidemiology in Cats

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and sampling methods [8, 5, 9]. A study in Hong Kong reported seroprevalence rates of approximately 37% in privately owned cats and 46% in community cats, with demographic factors such as age, outdoor access, and diet correlating with exposure [8]. In Jordan, seroprevalence in cats reached 43%, and PCR detection of T. gondii DNA in fecal samples confirmed active oocyst shedding in a subset of animals [5]. In Thailand, PCR-based screening of stray cat feces identified T. gondii DNA in 12% of samples, highlighting the potential for environmental contamination [10]. Genotype distribution studies in Bangladesh revealed that type II and type III clonal lineages predominate in feline populations [9].

Risk factors for feline seropositivity include free-roaming behavior, raw meat consumption, and cohabitation with multiple cats [8, 5]. Environmental degradation and social marginalisation have been linked to higher T. gondii exposure in human populations, often driven by free-roaming cat colonies that contaminate soil and water [4]. Veterinary medicine professionals and students in Mexico exhibited seroprevalence rates comparable to the general population, indicating occupational exposure risk [11]. Similarly, seroprevalence data from dogs in Brazil and deer in Iraq underscore the broad host range and environmental dissemination of oocysts shed by cats [12, 13].

Cat Toxoplasmosis Baby: Transplacental Transmission and Zoonotic Risk to Infants

The phrase "cat toxoplasmosis baby" reflects public health concerns regarding primary maternal infection during pregnancy and subsequent congenital transmission to the fetus [14, 15, 16, 17]. Although cats are the definitive host, direct transmission of toxoplasmosis from a cat to a baby typically occurs via ingestion of sporulated oocysts from contaminated litter boxes, soil, or food, rather than through direct contact [17]. Pregnant women who are seronegative for T. gondii and own cats are advised to practice rigorous hygiene: avoid changing litter boxes, wear gloves during gardening, and thoroughly wash produce [17]. Studies in Turkey have reported that women with a history of abortion or stillbirth show higher seropositivity for T. gondii, suggesting a potential link between primary infection and adverse pregnancy outcomes [14]. In Algeria, molecular and histopathological detection of T. gondii in aborted fetal goat myocardium provided direct evidence of congenital transmission in livestock, analogous to the risk in humans [18]. Similarly, T. gondii DNA has been detected in aborted equine fetuses in Brazil, reinforcing the concept of transplacental infection across species [19].

Surveys of pregnant women in Côte d'Ivoire and Iraq reveal that knowledge regarding toxoplasmosis prevention, including the role of cats and the risk to the unborn child, remains inadequate [15, 16]. Educational interventions that explain the rationale for avoiding cat litter exposure during pregnancy are therefore essential [17]. The association between childhood T. gondii infection and psychotic experiences has been explored in population-based cohort studies, indicating that congenital or early postnatal infection may have long-term neurodevelopmental consequences [20].

Clinical Signs and Pathology in Cats

Most immunocompetent cats infected with T. gondii remain subclinical, but clinical disease can occur, particularly in kittens or immunocompromised individuals [21]. Common clinical manifestations include ocular lesions (uveitis, chorioretinitis), pyogranulomatous and neutrophilic lymphadenitis, and neurological signs (seizures, ataxia, behavioral changes) [21, 34]. A retrospective study of 72 cats with lymphadenitis identified nine cases of steroid-responsive lymphadenitis, some of which were associated with toxoplasmosis [21]. Behavioural alterations in infected intermediate hosts have been described, and similar mechanisms may influence feline behaviour, though definitive evidence in cats remains limited [34].

Pathologically, T. gondii forms tissue cysts in the brain, skeletal muscle, and myocardium [7]. Acute infection can cause necrotizing inflammation in the lungs, liver, and central nervous system [21]. Fetal infection in cats can lead to abortion, stillbirth, or neonatal death [6]. Investigation of reproductive tissues from companion animals in a municipal neutering program detected T. gondii DNA in ovarian and testicular tissues, confirming that vertical transmission is possible in cats [6]. The AB blood group system phenotype in cats does not appear to influence susceptibility to infection [35].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological techniques [7, 5, 22]. Serological detection of anti-T. gondii antibodies (IgG and IgM) using enzyme-linked immunosorbent assays (ELISAs) is widely applied in veterinary practice [23, 24]. Double-antigen sandwich colloidal gold immunochromatographic strips have been developed and field-validated for rapid serological screening in multiple host species, including cats [23]. A SAG1-based immunochromatographic strip has also been validated for swine but can be adapted for feline use [24].

Molecular detection of T. gondii DNA by polymerase chain reaction (PCR) is highly sensitive and specific, especially for diagnosing active infection or confirming vertical transmission [10, 5, 22]. An antisense PCR assay has been developed specifically for domestic cats, improving detection sensitivity in fecal and tissue samples [22]. PCR of fecal samples from stray cats provides a direct measure of oocyst shedding [10, 5]. Molecular detection can also be applied to reproductive tissues and aborted fetal material to diagnose congenital toxoplasmosis [19, 18, 6].

The MIC17A antigen has been proposed as a marker for both entero-epithelial and chronic stages of infection, potentially enabling stage-specific diagnosis [7]. Histopathological examination of lymph node biopsies can reveal pyogranulomatous inflammation with intralesional tachyzoites [21]. Ocular toxoplasmosis is diagnosed via ophthalmological examination combined with serology or PCR of aqueous humor [25, 26].

Diagnostic Workflow for Suspected Feline Toxoplasmosis

flowchart TD
    A[Clinical suspicion: ocular, neurological, or lymphadenopathy signs], > B{Serological ELISA}
    B, >|IgM positive / rising IgG| C[Active or recent infection]
    B, >|IgG positive only| D[Chronic/latent infection; no oocyst shedding likely]
    C, > E{Confirm with PCR}
    E, >|Feces PCR positive| F[Oocyst shedding confirmed]
    E, >|Blood/tissue PCR positive| G[Systemic infection]
    D, > H[No further action unless immunocompromised]
    F, > I[Institute environmental precautions and treat cat]
    G, > J[Treat with antiprotozoal therapy]

Table 1: Diagnostic methods for feline toxoplasmosis

Treatment and Management

Antiprotozoal therapy is indicated in cats with clinical toxoplasmosis, particularly when ocular or neurological signs are present [21]. The standard regimen includes clindamycin hydrochloride administered orally or parenterally for two to four weeks. Alternative drugs include trimethoprim-sulfonamide combinations, pyrimethamine plus sulfadiazine, or azithromycin. Supportive care, including fluid therapy and nutritional support, is essential for debilitated cats [21]. Cats with steroid-responsive lymphadenitis may require concurrent immunosuppressive management after infectious causes are ruled out [21].

Oocyst shedding in feces typically resolves spontaneously but can be reduced with treatment early in infection. However, treatment does not eliminate tissue cysts [27]. The development of gene-edited live-attenuated vaccines against T. gondii has progressed, with recent advances focusing on deletion of genes essential for virulence or persistence in both feline and intermediate hosts [27, 28]. An mRNA-based vaccine incorporating conserved antigens has been proposed under a One Health framework [28]. Such vaccines aim to reduce oocyst shedding in cats and prevent congenital transmission in intermediate hosts [27, 28].

Control and Prevention

Control of feline toxoplasmosis and its zoonotic transmission requires multifaceted strategies. Housing cats indoors reduces predation and exposure to infected intermediate hosts [8]. Feeding only commercially cooked or processed cat food eliminates the risk of ingesting tissue cysts from raw meat [5]. Regular cleaning of litter boxes (daily disposal of feces) prevents oocyst sporulation, as freshly shed oocysts are not immediately infectious [17]. Pregnant women and immunocompromised individuals should avoid handling cat litter altogether [17].

Public health education targeting pregnant women and healthcare providers improves knowledge of risk factors and preventive measures [15, 16, 17]. Serological screening for T. gondii in pregnant women allows identification of seronegative individuals who require intensified counseling [14, 15]. In agricultural settings, controlling feral cat populations and preventing cat access to livestock feed reduces transmission to food animals [29, 30, 31]. Seroprevalence surveys in goats, sheep, cattle, and deer provide valuable data for risk assessment [12, 29, 18, 30].

Vaccination of cats remains an ongoing research goal. Live-attenuated vaccines generated by CRISPR-Cas9 gene editing show promise in reducing oocyst shedding and preventing tissue cyst formation [27]. A single-cell atlas of sexual development in the feline gut will facilitate identification of vaccine targets that block sexual replication [2].

One Health Implications

Toxoplasma gondii exemplifies a One Health pathogen with complex transmission dynamics involving feline definitive hosts, multiple intermediate hosts, and environmental persistence [4, 28]. Feline seroprevalence data inform risk maps for human exposure [4, 8, 5]. The parasite's ability to cause congenital disease in humans and domestic animals highlights the need for integrated surveillance across veterinary and public health sectors [19, 14, 18, 6]. Ocular toxoplasmosis is a leading cause of visual impairment in some populations, and its association with feline proximity has been documented in Quilombola communities in Brazil [26]. Moreover, T. gondii infection has been linked to behavioural outcomes in humans, including altered risk-taking and psychotic experiences, though causal pathways remain under investigation [20, 34].

Seroprevalence studies in diverse species, including dogs [13], goats [29], cattle [30, 31], pigs [31], deer [12], and sickle cell disease patients [32], provide a comprehensive picture of environmental contamination. The detection of T. gondii in an aborted equine fetus further emphasizes the reproductive consequences of infection in livestock [19]. Renal transplant recipients are also at risk of cerebral toxoplasmosis, underscoring the importance of preventing primary infection through feline management [33].

Conclusion

Toxoplasmosis in cats represents a significant zoonotic concern, primarily due to oocyst shedding and the risk of congenital transmission to human infants and animal offspring. Understanding the parasite's life cycle, particularly the sexual replication phase in the feline intestine, is critical for developing effective interventions. Advances in diagnostics, including immunochromatographic strips and antisense PCR, enhance detection capabilities in veterinary practice. Gene-edited vaccines offer future potential for reducing oocyst shedding and preventing congenital infections. Public health measures, including education on cat toxoplasmosis baby risks, remain the cornerstone of prevention.

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[4] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[5] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[6] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[7] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[8] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[9] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/

[10] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[11] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[12] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[13] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[14] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[15] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[16] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[17] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[18] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[19] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[20] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[21] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a

[22] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[23] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[24] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[25] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[26] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[27] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[28] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[29] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[30] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[31] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[32] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[33] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/